Cargando…
Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
The atypical antipsychotics (AAPs) have been used as first-line drugs in psychiatric practice for a wide range of psychotic disorders, including schizophrenia and bipolar mania. While effectively exerting therapeutic effects on positive and negative symptoms, as well as cognitive impairments in schi...
Autores principales: | Xu, Haiyun, Zhuang, Xiaoyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659786/ https://www.ncbi.nlm.nih.gov/pubmed/31413575 http://dx.doi.org/10.2147/NDT.S208061 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis
por: Hatem, Reem, et al.
Publicado: (2022) -
Nonalcoholic Fatty Liver Disease in Nonobese Subjects of African Origin Has Atypical Metabolic Characteristics
por: Thompson, Debbie S, et al.
Publicado: (2019) -
Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease
por: Karakousis, Nikolaos D., et al.
Publicado: (2022) -
Influence of the use of atypical antipsychotics in metabolic syndrome
por: Doménech-Matamoros, P
Publicado: (2020) -
Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)